Enveda
Enveda uses AI to discover biologically active molecules from nature and develop them into small-molecule medicines for inflammatory and metabolic diseases.
$311MSeries E
ParticipantTR
T. Rowe Price Investment Management
Activity from announced rounds
Activity in this selectionSeries C+
- Rounds participated in
- 4
- Confirmed lead rounds
- 1 2 roles undisclosed
- New companies
- 4 First participation on record · 0 follow-on
- Funding in participating rounds
- $1.7B 4 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
4 in this selectionFORM ENERGY
Long-duration iron-air batteries designed to store electricity for multi-day grid needs.
$750MSeries G
LeadSiFive
SiFive licenses RISC-V processor intellectual property for custom computing chips, including high-performance data-centre designs.
$400MSeries G
Role not disclosedCellares
Develops automated cell therapy manufacturing platforms
$257MSeries D
Role not disclosed